Development of in-House Synthesis and Quality Control of [(99m)Tc]Tc-PSMA-I&S

Many radioactive PSMA inhibitory substances have already been developed for PET diagnostics and therapy of prostate cancer. Because PET radionuclides and instrumentation may not be available, technetium-99 m labelled tracers can be considered as a diagnostic alternative. A suitable tracer is [(99m)T...

Descripción completa

Detalles Bibliográficos
Autores principales: Plhak, Elisabeth, Pichler, Christopher, Gößnitzer, Edith, Aigner, Reingard M., Kvaternik, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864623/
https://www.ncbi.nlm.nih.gov/pubmed/36677636
http://dx.doi.org/10.3390/molecules28020577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864623/
https://www.ncbi.nlm.nih.gov/pubmed/36677636
http://dx.doi.org/10.3390/molecules28020577

Ejemplares similares